Chloe Skidmore alias Dr. Anecdote
consulting from the wellness trough at True Health
Website · truehealthks.com
Practice location
603 E Lincoln Blvd
Hesston, KS 67062
Funnel-first framing that runs on persuasion, light on published evidence.
Oh, look at Chloe Skidmore, the 'functional holistic doctor' who's too busy diagnosing diabetes and heart disease to remember she's just a chiropractor! She's got the perfect grift: scare patients that traditional medicine misses 'root causes,' then sell them expensive specialty labs and unproven nutraceuticals—all cash-only, no insurance, and zero disclosure. She's the queen of the 'root cause' racket, turning vague symptoms into a cash cow for her nutraceutical empire.
High grift signals
Score breakdown
Direct answer
Chloe Skidmore is licensed in Kansas as a chiropractor (DC), not as an MD or DO, and Kansas's chiropractic scope statute (K.S.A. chiropractic practice definition as summarized in Kansas scope overview) limits that license to musculoskeletal care, not the diagnosis or treatment of systemic disease. Even so, they advertise diagnosing or treating Thyroid conditions, Autoimmunity, Hashimoto’s, IBS & SIBO, and Anxiety & Depression, conditions that belong with rheumatologists, endocrinologists, and gastroenterologists. Those same pages route patients toward supplements, lab panels, and paid programs that Chloe Skidmore profits from.
Key findings
- False Authority: A chiropractor (DC) is licensed for musculoskeletal/spine care, not for diagnosing or managing systemic internal diseases like diabetes or heart disease. Using 'Dr.' and 'holistic doctor' to imply general medical competence is a classic false authority grift.see section ↓
- Claim "Diagnosing and managing diabetes, heart disease, hormonal imbalances, and digestive probl…": mixed in the medical literature.see section ↓
- Claim "Prescribing natural supplements to treat root causes of chronic disease": mixed in the medical literature.see section ↓
- NPI registry confirms Chloe Skidmore as Chiropractor (DC) in Kansas (NPI 1336723535).see section ↓
- Chloe Skidmore shows credential inflation relative to stated vs likely credentials.see section ↓
- Dr Chloe Skidmore is marketed with a doctor title, but reviewed credentials indicate Chiropractor (DC) rather than an MD/DO physician license.see section ↓
- Against Kansas State Board of Healing Arts (Chiropractic) scope rules (K.S.A. chiropractic practice definition as summarized in Kansas scope overview), these advertised activities appear outside Chloe Skidmore's license (including conditions they merely list as ones they treat): Diagnosing and…see section ↓
- 19 of 20 advertised activities fall outside permitted Chiropractor scope in KS.see section ↓
Claims & evidence
15 advertised conditions or treatments fall outside their license scope. Each box leads with state-board scope notation; literature cross-check follows when we matched a specific claim. Every card carries its receipts: the quoted wording, a live source link, and an archived copy.
Chloe Skidmore is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Diagnosing and managing diabetes, heart disease, hormonal imbalances, and digestive problems.
Diagnosing and managing diabetes, heart disease, hormonal imbalances, and digestive problems
- Supports
- High-quality evidence strongly supports that diabetes and heart disease require formal diagnostic criteria, structured risk assessment, and guideline-based management rather than informal or self-directed approaches. Major guidelines from diabetes and cardiology societies define diabetes using thresholds for fasting plasma glucose, HbA1c, oral glucose tolerance tests, and random glucose, and recommend confirmation with a second abnormal test.[17] These same guidelines emphasize comprehensive cardiovascular risk factor management (blood pressure, lipids, lifestyle, antiplatelet therapy when indicated) as central to care in people with diabetes and heart disease.[3][5][9][17][20][23] Evidence from randomized trials and meta-analyses shows that statins and other lipid-lowering drugs substantially reduce major coronary events in both diabetic and non-diabetic patients, underscoring that cardiovascular disease must be actively treated with proven therapies.[10] In type 2 diabetes with heart failure or high cardiovascular risk, systematic reviews and meta-analyses of large randomized controlled trials and observational studies show that SGLT2 inhibitors reduce cardiovascular death and heart failure hospitalization and improve survival, leading guidelines to position them as key disease-modifying drugs.[1][2][11][15][18][21][24] For digestive problems, high-quality guidance for functional gastrointestinal disorders supports a structured biopsychosocial management approach (diet and lifestyle modification, psychological interventions, and targeted medications), rather than unstructured influencer-directed strategies.[25] Hormonal changes (e.g., across the menstrual cycle or menopause) can influence bowel habits and digestive symptoms, and clinical sources recommend evidence-based management such as dietary adjustment, fiber, hydration, exercise, and medical therapies when indicated, aligning with the concept that hormonal and digestive issues should be medically evaluated but not casually self-managed.[13][16][19][22][25]
- Contradicts
- The indexed SGLT2 inhibitor reviews are formal peer critiques of a systematic review on SGLT2 inhibitors in type 2 diabetes and heart failure outcomes, focusing on methodological rigor and real-world evidence; they do not support broad, non-specific claims that a single influencer can personally “diagnose and manage” diabetes, heart disease, hormonal imbalances, and digestive problems across populations. Evidence-based guidelines emphasize that diagnosis of diabetes and cardiovascular disease must follow standardized tests and risk assessment tools, typically performed and interpreted by trained clinicians using validated criteria, not informal or unstructured assessments.[3][11][17][20][23] Major position statements stress multidisciplinary, long-term care plans with specific pharmacologic and lifestyle interventions, which contradict any implication that complex conditions like diabetes, heart failure, hormonal disorders, or functional GI problems can be reliably diagnosed or managed by an influencer without formal medical training, appropriate investigations, or longitudinal follow-up.[5][6][7][8][9][17][20][23][25] For hormonal imbalance and digestive problems, current evidence and expert sources highlight that symptoms are often nonspecific, overlap with other diseases, and require careful differential diagnosis; this contradicts simplistic claim frameworks in which an influencer suggests they can broadly diagnose “hormonal imbalance” or “digestive problems” without structured evaluation, testing, or understanding of comorbidities.[13][16][19][22][25]
- Mainstream view
- Mainstream medical practice holds that diagnosing and managing diabetes, heart disease, hormonal disorders, and digestive conditions must be done within a regulated clinical framework using standardized diagnostic criteria, appropriate laboratory and imaging tests, and guideline-directed therapies. For diabetes, mainstream guidelines define diagnosis through specific glucose and HbA1c thresholds confirmed by repeat testing, and management through individualized glycemic targets, lifestyle modification, and evidence-based medications (e.g., metformin, SGLT2 inhibitors, GLP-1 receptor agonists), with systematic cardiovascular risk assessment and treatment.[1][2][3][5][6][9][11][17][20][23][24] For heart disease in people with diabetes, professional societies recommend aggressive risk-factor control, early detection of heart failure, use of cardioprotective drugs like statins, ACE inhibitors/ARBs, and SGLT2 inhibitors, and structured follow-up.[5][9][10][11][15][17][18][20][21][23][24] For hormonal imbalances and digestive problems, the mainstream view is that these are heterogeneous diagnoses often requiring endocrinology and gastroenterology input, targeted testing (e.g., hormone panels, imaging, endoscopy), and structured biopsych Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“My expertise spans diagnosing and managing chronic conditions, such as diabetes, heart disease, hormonal imbalances, and digestive problems”
Rule: K.S.A. chiropractic practice definition as summarized in Kansas scope overview
Chloe Skidmore is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Thyroid conditions.
Thyroid conditions
- Supports
- Among thyroid conditions, Hashimoto thyroiditis (chronic autoimmune hypothyroidism) is the main area where supplementation claims are discussed. High‑quality evidence now includes multiple systematic reviews and meta‑analyses of randomized trials showing that selenium supplementation can lower thyroid peroxidase antibody (TPOAb) titers and modestly reduce TSH in patients with Hashimoto thyroiditis, especially those not yet on thyroid hormone replacement therapy. [5][7][9][10][11][12] More recent meta‑analyses and overviews (outside the provided refs) similarly report that selenium, particularly 200 µg/day selenomethionine, reduces TPOAb and sometimes TSH over 3–6 months, with moderate‑quality evidence and generally good short‑term safety. This supports a limited claim that selenium can favorably modify some biochemical markers of Hashimoto thyroiditis, though not necessarily clinical outcomes such as symptoms or need for levothyroxine. [8] Major thyroid guidelines (e. g. , ATA, NICE, AACE) acknowledge the autoimmune nature of Hashimoto thyroiditis and the importance of appropriate thyroid hormone replacement but do not recommend against standard treatment; a claim that thyroid conditions are real, common, and require structured assessment and management is therefore strongly supported.
- Contradicts
- Even the key systematic review and meta‑analysis of selenium in Hashimoto thyroiditis concludes that while selenium lowers TPOAb and TSH in some subgroups, it does not significantly change free T4, free T3, thyroglobulin antibodies, thyroid volume, or clear clinical endpoints, and the certainty of evidence is only moderate. [5][7][8][9][10] Earlier high‑quality evidence, including a Cochrane‑style review, found insufficient documentation for clinically meaningful benefits of selenium supplementation in chronic autoimmune thyroiditis, highlighting heterogeneous trials, small sample sizes, short duration, and lack of robust clinical outcome data. [11] More recent RCT data show that in hypothyroid patients already on levothyroxine due to autoimmune thyroiditis, selenium and placebo both improve quality of life similarly, and selenium does not reduce levothyroxine dose requirements, suggesting limited or no clinical advantage over placebo despite antibody reductions. [12] Major guidelines for thyroid disease management emphasize levothyroxine for overt hypothyroidism and do not recommend routine selenium supplementation as standard care for Hashimoto thyroiditis or other thyroid conditions; any influencer claim that selenium alone can treat or reverse thyroid disease, replace thyroid hormone, or is broadly recommended in guidelines is therefore contradicted by current evidence and guideline positions. [6]
- Mainstream view
- The mainstream medical view is that thyroid conditions—including Hashimoto thyroiditis (autoimmune hypothyroidism), Graves disease (autoimmune hyperthyroidism), and other causes—are common, well‑characterized disorders that should be managed with established, guideline‑driven therapies such as levothyroxine for hypothyroidism and antithyroid drugs, radioiodine, or surgery for hyperthyroidism, with care individualized based on TSH, thyroid hormone levels, etiology, and clinical status. [6][7][11] Selenium is recognized as an essential trace element with a biological role in thyroid hormone metabolism and antioxidant defense, and recent meta‑analyses show it can lower thyroid antibody titers and modestly reduce TSH in some patients with Hashimoto thyroiditis, especially those not yet on thyroid hormone replacement therapy. [5][9][10] However, mainstream guidelines currently view selenium supplementation as an optional, experimental or adjunctive intervention rather than standard of care; they do not recommend routine selenium for all patients with autoimmune thyroid disease because evidence for meaningful, long‑term clinical benefit (symptom relief, reduced progression to hypothyroidism, or reduced need for levothyroxine) remains limited and heterogeneous. [8][12] Clinicians may consider a time‑limited trial of selenium in selected Hashimoto patients, particularly in regions of low selenium status and with high antibody titers, but it is not a substitute for appropriate diagnosis and thyroid hormone replacement when indicated.
“Thyroid conditions”
Rule: K.S.A. chiropractic practice definition (diagnosis by physical methods)[3]
Chloe Skidmore is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Autoimmunity.
Autoimmunity
No specific health claims of theirs were cross-checked against the literature.
“Autoimmunity”
Rule: K.S.A. chiropractic practice definition (treat the human body by manual, mechanical, electrical or natural methods)[3]
Chloe Skidmore is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Hashimoto’s.
Hashimoto’s
No specific health claims of theirs were cross-checked against the literature.
“Hashimoto’s”
Rule: K.S.A. chiropractic practice definition (diagnose the human living body and its diseases by physical methods)[3]
Chloe Skidmore is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure IBS & SIBO.
IBS & SIBO
No specific health claims of theirs were cross-checked against the literature.
“IBS & SIBO”
Rule: K.S.A. chiropractic practice definition (foods, food concentrates, or food extracts; physical methods)[3]
Chloe Skidmore is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Anxiety & Depression.
Anxiety & Depression
No specific health claims of theirs were cross-checked against the literature.
“Anxiety & Depression”
Rule: K.S.A. chiropractic practice definition (diagnose by physical, thermal, or manual method)[3]
Chloe Skidmore is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Type II Diabetes.
Type II Diabetes
No specific health claims of theirs were cross-checked against the literature.
“Type II Diabetes”
Rule: K.S.A. chiropractic practice definition (treat by foods, food concentrates, or food extracts; prohibition on prescribing medicines or drugs)[1][3]
Chloe Skidmore is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure PCOS & Endometriosis.
PCOS & Endometriosis
No specific health claims of theirs were cross-checked against the literature.
“PCOS & Endometriosis”
Rule: K.S.A. chiropractic practice definition (examine and diagnose by physical methods; treat via natural methods)[3]
Chloe Skidmore is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Chronic Fatigue.
Chronic Fatigue
No specific health claims of theirs were cross-checked against the literature.
“Chronic Fatigue”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Chloe Skidmore is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Fertility and pregnancy support.
Fertility and pregnancy support
- Supports
- High-quality evidence supports a limited but real role for specific medical and nutritional interventions in improving certain fertility and pregnancy outcomes, particularly in women with ovarian aging or diminished ovarian reserve, and in selected thyroid conditions. A recent systematic review and meta-analysis of randomized trials in women with ovarian aging found that antioxidant supplements (including coenzyme Q10, melatonin, myo‑inositol, and vitamins) significantly increased the number of retrieved oocytes, high‑quality embryos, and clinical pregnancy rates while reducing gonadotropin dose, with coenzyme Q10 showing the most pronounced benefit. [20][24][26] This supports the idea that targeted antioxidant therapy can modestly improve fertility parameters in women with ovarian aging. The systematic review and meta-analysis of therapeutic management in women with diminished ovarian reserve (DOR) reports that oral nutritional supplements such as vitamins, coenzyme Q10, and DHEA can reduce FSH, increase AMH and antral follicle count, increase oocyte and high‑quality embryo numbers, and improve clinical pregnancy rates in DOR women undergoing IVF/ICSI, although the recommendation is weak and framed as complementary therapy rather than primary treatment. [23] For thyroid-related fertility, a systematic review and meta-analysis of randomized controlled trials on levothyroxine treatment in women with subclinical hypothyroidism (SCH) examined fertility and pregnancy outcomes, indicating that thyroid hormone replacement can be clinically relevant in a subset of women with thyroid-related fertility issues, although effects on live birth and pregnancy outcomes are nuanced. [21] Regarding structural uterine factors, a systematic review and meta-analysis of fibroids and natural fertility supports that fibroids may interfere with natural fertility, and other evidence indicates that fertility-sparing surgical management (e. [22] g. , myomectomy for submucosal fibroids) can improve pregnancy rates in infertile women, thereby indirectly supporting the claim that appropriate medical/surgical management can aid fertility and subsequent pregnancy. Overall, these high-quality studies support the concept that evidence-based, condition-specific interventions (antioxidants in ovarian aging/DOR, levothyroxine in selected thyroid conditions, surgery for fibroids) can enhance fertility and support pregnancy in defined clinical populations, but they do not support broad, universal claims that generic supplements alone reliably “support fertility and pregnancy” for all women. [25][27]
- Contradicts
- Evidence also indicates important limitations and contradictions that weaken broad claims of fertility and pregnancy support, especially for generalized supplement use. [25] The systematic review and meta-analysis of antioxidants in women with ovarian aging shows improvements in intermediate fertility markers and clinical pregnancy rates, but it does not demonstrate strong or consistent effects on live birth rates, and benefits are most evident with coenzyme Q10 at specific doses and timing rather than with all antioxidants or supplement regimens. [20][22][23][24][26][27] The DOR management meta-analysis likewise concludes that oral nutritional supplements may help and have “certain clinical value” but only supports a weak recommendation, emphasizing that these are complementary therapies and that evidence quality and consistency are limited. The systematic review and meta-analysis of levothyroxine treatment in subclinical hypothyroidism examines fertility and pregnancy outcomes and highlights that levothyroxine does not uniformly improve live birth, miscarriage, or overall pregnancy outcomes across all women with SCH, contradicting any blanket claim that thyroid hormone therapy broadly enhances fertility or pregnancy in mild thyroid dysfunction. [21] The fibroids and natural fertility meta-analysis specifically notes that epidemiological data suggest but do not definitively demonstrate that fibroids interfere with natural fertility, indicating that the relationship between fibroids, fertility, and pregnancy is complex and not fully resolved. This undermines overly simplistic claims that any treatment for fibroids automatically supports fertility and pregnancy without careful patient selection and evidence-based management. Taken together, these findings contradict strong, generalized influencer-style claims that supplements or single interventions reliably “support fertility and pregnancy” across the board. Benefits are conditional, modest, and dependent on the underlying diagnosis, with notable gaps in high‑quality data on live birth and long‑term pregnancy outcomes.
- Mainstream view
- The mainstream medical and scientific position is that fertility and pregnancy outcomes are best supported through comprehensive, diagnosis-driven care rather than generic supplement-based approaches. [21][22][26][27] Current evidence and specialist guidelines support individualized evaluation of women with infertility or adverse pregnancy outcomes, including assessment of ovarian reserve, thyroid function, uterine anatomy (e. g. , fibroids), and other systemic factors. In women with ovarian aging or diminished ovarian reserve, mainstream practice recognizes that certain antioxidant or nutritional regimens (especially coenzyme Q10 and related supplements [20][23][24]
“thyroid conditions, hormones, fertility, and pregnancy support”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Chloe Skidmore is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Immune dysregulation.
Immune dysregulation
- Supports
- Immune dysregulation is a well-established medical concept describing breakdown or maladaptive change in the molecular and cellular control of immune responses, leading to autoimmunity, hyperinflammation, impaired host defense, or inappropriate tolerance to tumors. Contemporary reviews and editorials on immune dysregulation in inborn errors of immunity, immune-mediated inflammatory diseases, and primary immunodeficiency consistently describe dysregulated immunity as a core mechanism in many conditions, not a fringe idea.[2][3][5][7] Clinical nutrition guidelines for complex inflammatory conditions, such as inflammatory bowel disease, explicitly acknowledge that chronic intestinal inflammation is driven by abnormal immune responses to luminal antigens and that nutrition support is tailored within this context of immune and inflammatory dysregulation.[2][14][20] ESPEN guidelines on clinical nutrition in inflammatory bowel disease describe IBD as a chronic immune-mediated condition in which both innate and adaptive immune pathways are aberrantly activated, and they integrate nutritional strategies alongside drugs that target immune dysregulation (e.g., biologics against TNF, integrins, IL-12/23).[14][20] ASPEN-FELANPE and other major nutrition guidelines emphasize that malnutrition, micronutrient deficiencies, and inappropriate use of parenteral versus enteral nutrition can adversely affect immune function, implicitly recognizing that immune regulation is sensitive to nutritional status even if the term “immune dysregulation” is not always used.[19][24] The PREV-HAP interferon-γ1b trial in critically ill patients is grounded in the accepted concept of critical-illness-related immunosuppression (an acquired form of immune dysregulation) and attempts to restore immune competence pharmacologically, reflecting mainstream acceptance that immune function becomes pathologically altered in severe illness.[21] Primary immune regulatory disorders and inborn errors of immunity are formally classified groups of diseases where immune dysregulation (autoimmunity, lymphoproliferation, hyperinflammation) is the defining mechanism, further supporting the legitimacy of the concept in contemporary immunology and clinical practice.[2][3][5][7][22]
- Contradicts
- The claim as given, “Immune dysregulation,” is extremely broad and lacks a specific causal, diagnostic, or therapeutic assertion; major guidelines do not support nonspecific, catch-all uses that imply immune dysregulation is an explanation for all symptoms or a standalone diagnosis without defined criteria.[14][19] High-quality hypertension management guidelines, for example, focus on vascular biology, neurohormonal control, and lifestyle factors rather than labeling hypertension broadly as immune dysregulation, illustrating that mainstream guidelines use more precise pathophysiologic frameworks.[0] ASPEN-FELANPE and ESPEN guidelines, while acknowledging interactions between nutrition and immune function, do not endorse routine immune-targeted supplements or parenteral nutrition solely to “fix immune dysregulation” in the absence of specific indications; they emphasize evidence-based indications, safety, and the primacy of enteral nutrition when feasible.[1][3][19][20] The PREV-HAP randomized controlled trial shows that simply boosting one immune pathway (interferon-γ1b) in critically ill patients did not reduce pneumonia or mortality and was stopped early for safety, contradicting simplistic influencer narratives that enhancing immune activity is uniformly beneficial in states of presumed immune dysregulation.[21][15] Editorials on innate immune regulation highlight that mechanisms of immune dysregulation are complex, multifactorial, and still not fully understood, cautioning against oversimplified claims that minor lifestyle changes can reliably “reset” or “rebalance” immune regulation in serious disease.[6] Overall, the rigorous literature supports immune dysregulation as a specific mechanistic concept tied to defined diseases, but not as an imprecise, universal explanation or easy therapeutic target in the way influencers often present it.
- Mainstream view
- Mainstream immunology and clinical medicine recognize immune dysregulation as a central mechanism in many conditions including autoimmune diseases, primary immune regulatory disorders, inborn errors of immunity, chronic inflammatory diseases (such as IBD), some cancers, and states like critical-illness-related immunosuppression.[2][3][5][7][9][14][20][21][22] It is viewed as a spectrum of abnormal immune control—ranging from insufficient responses (immunodeficiency) to excessive or misdirected responses (autoimmunity, hyper
“gut health, hormonal dysfunction, environmental toxins, immune dysregulation or food sensitivities”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Chloe Skidmore is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise More About Conditions Seen as within their scope of practice.
More About Conditions Seen
No specific health claims of theirs were cross-checked against the literature.
“More About Conditions Seen”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Chloe Skidmore is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise Diagnosing immune dysregulation and food sensitivities via specialty labs as within their scope of practice.
Diagnosing immune dysregulation and food sensitivities via specialty labs
- Supports
- Immune dysregulation is a well-established medical concept describing breakdown or maladaptive change in the molecular and cellular control of immune responses, leading to autoimmunity, hyperinflammation, impaired host defense, or inappropriate tolerance to tumors. Contemporary reviews and editorials on immune dysregulation in inborn errors of immunity, immune-mediated inflammatory diseases, and primary immunodeficiency consistently describe dysregulated immunity as a core mechanism in many conditions, not a fringe idea.[2][3][5][7] Clinical nutrition guidelines for complex inflammatory conditions, such as inflammatory bowel disease, explicitly acknowledge that chronic intestinal inflammation is driven by abnormal immune responses to luminal antigens and that nutrition support is tailored within this context of immune and inflammatory dysregulation.[2][14][20] ESPEN guidelines on clinical nutrition in inflammatory bowel disease describe IBD as a chronic immune-mediated condition in which both innate and adaptive immune pathways are aberrantly activated, and they integrate nutritional strategies alongside drugs that target immune dysregulation (e.g., biologics against TNF, integrins, IL-12/23).[14][20] ASPEN-FELANPE and other major nutrition guidelines emphasize that malnutrition, micronutrient deficiencies, and inappropriate use of parenteral versus enteral nutrition can adversely affect immune function, implicitly recognizing that immune regulation is sensitive to nutritional status even if the term “immune dysregulation” is not always used.[19][24] The PREV-HAP interferon-γ1b trial in critically ill patients is grounded in the accepted concept of critical-illness-related immunosuppression (an acquired form of immune dysregulation) and attempts to restore immune competence pharmacologically, reflecting mainstream acceptance that immune function becomes pathologically altered in severe illness.[21] Primary immune regulatory disorders and inborn errors of immunity are formally classified groups of diseases where immune dysregulation (autoimmunity, lymphoproliferation, hyperinflammation) is the defining mechanism, further supporting the legitimacy of the concept in contemporary immunology and clinical practice.[2][3][5][7][22]
- Contradicts
- The claim as given, “Immune dysregulation,” is extremely broad and lacks a specific causal, diagnostic, or therapeutic assertion; major guidelines do not support nonspecific, catch-all uses that imply immune dysregulation is an explanation for all symptoms or a standalone diagnosis without defined criteria.[14][19] High-quality hypertension management guidelines, for example, focus on vascular biology, neurohormonal control, and lifestyle factors rather than labeling hypertension broadly as immune dysregulation, illustrating that mainstream guidelines use more precise pathophysiologic frameworks.[0] ASPEN-FELANPE and ESPEN guidelines, while acknowledging interactions between nutrition and immune function, do not endorse routine immune-targeted supplements or parenteral nutrition solely to “fix immune dysregulation” in the absence of specific indications; they emphasize evidence-based indications, safety, and the primacy of enteral nutrition when feasible.[1][3][19][20] The PREV-HAP randomized controlled trial shows that simply boosting one immune pathway (interferon-γ1b) in critically ill patients did not reduce pneumonia or mortality and was stopped early for safety, contradicting simplistic influencer narratives that enhancing immune activity is uniformly beneficial in states of presumed immune dysregulation.[21][15] Editorials on innate immune regulation highlight that mechanisms of immune dysregulation are complex, multifactorial, and still not fully understood, cautioning against oversimplified claims that minor lifestyle changes can reliably “reset” or “rebalance” immune regulation in serious disease.[6] Overall, the rigorous literature supports immune dysregulation as a specific mechanistic concept tied to defined diseases, but not as an imprecise, universal explanation or easy therapeutic target in the way influencers often present it.
- Mainstream view
- Mainstream immunology and clinical medicine recognize immune dysregulation as a central mechanism in many conditions including autoimmune diseases, primary immune regulatory disorders, inborn errors of immunity, chronic inflammatory diseases (such as IBD), some cancers, and states like critical-illness-related immunosuppression.[2][3][5][7][9][14][20][21][22] It is viewed as a spectrum of abnormal immune control—ranging from insufficient responses (immunodeficiency) to excessive or misdirected responses (autoimmunity, hyper
“gut health, hormonal dysfunction, environmental toxins, immune dysregulation or food sensitivities”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Chloe Skidmore is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise Managing fertility and pregnancy support as medical treatment as within their scope of practice.
Managing fertility and pregnancy support as medical treatment
- Supports
- High-quality evidence supports a limited but real role for specific medical and nutritional interventions in improving certain fertility and pregnancy outcomes, particularly in women with ovarian aging or diminished ovarian reserve, and in selected thyroid conditions. A recent systematic review and meta-analysis of randomized trials in women with ovarian aging found that antioxidant supplements (including coenzyme Q10, melatonin, myo‑inositol, and vitamins) significantly increased the number of retrieved oocytes, high‑quality embryos, and clinical pregnancy rates while reducing gonadotropin dose, with coenzyme Q10 showing the most pronounced benefit. [20][24][26] This supports the idea that targeted antioxidant therapy can modestly improve fertility parameters in women with ovarian aging. The systematic review and meta-analysis of therapeutic management in women with diminished ovarian reserve (DOR) reports that oral nutritional supplements such as vitamins, coenzyme Q10, and DHEA can reduce FSH, increase AMH and antral follicle count, increase oocyte and high‑quality embryo numbers, and improve clinical pregnancy rates in DOR women undergoing IVF/ICSI, although the recommendation is weak and framed as complementary therapy rather than primary treatment. [23] For thyroid-related fertility, a systematic review and meta-analysis of randomized controlled trials on levothyroxine treatment in women with subclinical hypothyroidism (SCH) examined fertility and pregnancy outcomes, indicating that thyroid hormone replacement can be clinically relevant in a subset of women with thyroid-related fertility issues, although effects on live birth and pregnancy outcomes are nuanced. [21] Regarding structural uterine factors, a systematic review and meta-analysis of fibroids and natural fertility supports that fibroids may interfere with natural fertility, and other evidence indicates that fertility-sparing surgical management (e. [22] g. , myomectomy for submucosal fibroids) can improve pregnancy rates in infertile women, thereby indirectly supporting the claim that appropriate medical/surgical management can aid fertility and subsequent pregnancy. Overall, these high-quality studies support the concept that evidence-based, condition-specific interventions (antioxidants in ovarian aging/DOR, levothyroxine in selected thyroid conditions, surgery for fibroids) can enhance fertility and support pregnancy in defined clinical populations, but they do not support broad, universal claims that generic supplements alone reliably “support fertility and pregnancy” for all women. [25][27]
- Contradicts
- Evidence also indicates important limitations and contradictions that weaken broad claims of fertility and pregnancy support, especially for generalized supplement use. [25] The systematic review and meta-analysis of antioxidants in women with ovarian aging shows improvements in intermediate fertility markers and clinical pregnancy rates, but it does not demonstrate strong or consistent effects on live birth rates, and benefits are most evident with coenzyme Q10 at specific doses and timing rather than with all antioxidants or supplement regimens. [20][22][23][24][26][27] The DOR management meta-analysis likewise concludes that oral nutritional supplements may help and have “certain clinical value” but only supports a weak recommendation, emphasizing that these are complementary therapies and that evidence quality and consistency are limited. The systematic review and meta-analysis of levothyroxine treatment in subclinical hypothyroidism examines fertility and pregnancy outcomes and highlights that levothyroxine does not uniformly improve live birth, miscarriage, or overall pregnancy outcomes across all women with SCH, contradicting any blanket claim that thyroid hormone therapy broadly enhances fertility or pregnancy in mild thyroid dysfunction. [21] The fibroids and natural fertility meta-analysis specifically notes that epidemiological data suggest but do not definitively demonstrate that fibroids interfere with natural fertility, indicating that the relationship between fibroids, fertility, and pregnancy is complex and not fully resolved. This undermines overly simplistic claims that any treatment for fibroids automatically supports fertility and pregnancy without careful patient selection and evidence-based management. Taken together, these findings contradict strong, generalized influencer-style claims that supplements or single interventions reliably “support fertility and pregnancy” across the board. Benefits are conditional, modest, and dependent on the underlying diagnosis, with notable gaps in high‑quality data on live birth and long‑term pregnancy outcomes.
- Mainstream view
- The mainstream medical and scientific position is that fertility and pregnancy outcomes are best supported through comprehensive, diagnosis-driven care rather than generic supplement-based approaches. [21][22][26][27] Current evidence and specialist guidelines support individualized evaluation of women with infertility or adverse pregnancy outcomes, including assessment of ovarian reserve, thyroid function, uterine anatomy (e. g. , fibroids), and other systemic factors. In women with ovarian aging or diminished ovarian reserve, mainstream practice recognizes that certain antioxidant or nutritional regimens (especially coenzyme Q10 and related supplements [20][23][24]
“thyroid conditions, hormones, fertility, and pregnancy support”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Chloe Skidmore is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise Specialty lab testing for immune dysregulation and food sensitivities as within their scope of practice.
Specialty lab testing for immune dysregulation and food sensitivities
- Supports
- Immune dysregulation is a well-established medical concept describing breakdown or maladaptive change in the molecular and cellular control of immune responses, leading to autoimmunity, hyperinflammation, impaired host defense, or inappropriate tolerance to tumors. Contemporary reviews and editorials on immune dysregulation in inborn errors of immunity, immune-mediated inflammatory diseases, and primary immunodeficiency consistently describe dysregulated immunity as a core mechanism in many conditions, not a fringe idea.[2][3][5][7] Clinical nutrition guidelines for complex inflammatory conditions, such as inflammatory bowel disease, explicitly acknowledge that chronic intestinal inflammation is driven by abnormal immune responses to luminal antigens and that nutrition support is tailored within this context of immune and inflammatory dysregulation.[2][14][20] ESPEN guidelines on clinical nutrition in inflammatory bowel disease describe IBD as a chronic immune-mediated condition in which both innate and adaptive immune pathways are aberrantly activated, and they integrate nutritional strategies alongside drugs that target immune dysregulation (e.g., biologics against TNF, integrins, IL-12/23).[14][20] ASPEN-FELANPE and other major nutrition guidelines emphasize that malnutrition, micronutrient deficiencies, and inappropriate use of parenteral versus enteral nutrition can adversely affect immune function, implicitly recognizing that immune regulation is sensitive to nutritional status even if the term “immune dysregulation” is not always used.[19][24] The PREV-HAP interferon-γ1b trial in critically ill patients is grounded in the accepted concept of critical-illness-related immunosuppression (an acquired form of immune dysregulation) and attempts to restore immune competence pharmacologically, reflecting mainstream acceptance that immune function becomes pathologically altered in severe illness.[21] Primary immune regulatory disorders and inborn errors of immunity are formally classified groups of diseases where immune dysregulation (autoimmunity, lymphoproliferation, hyperinflammation) is the defining mechanism, further supporting the legitimacy of the concept in contemporary immunology and clinical practice.[2][3][5][7][22]
- Contradicts
- The claim as given, “Immune dysregulation,” is extremely broad and lacks a specific causal, diagnostic, or therapeutic assertion; major guidelines do not support nonspecific, catch-all uses that imply immune dysregulation is an explanation for all symptoms or a standalone diagnosis without defined criteria.[14][19] High-quality hypertension management guidelines, for example, focus on vascular biology, neurohormonal control, and lifestyle factors rather than labeling hypertension broadly as immune dysregulation, illustrating that mainstream guidelines use more precise pathophysiologic frameworks.[0] ASPEN-FELANPE and ESPEN guidelines, while acknowledging interactions between nutrition and immune function, do not endorse routine immune-targeted supplements or parenteral nutrition solely to “fix immune dysregulation” in the absence of specific indications; they emphasize evidence-based indications, safety, and the primacy of enteral nutrition when feasible.[1][3][19][20] The PREV-HAP randomized controlled trial shows that simply boosting one immune pathway (interferon-γ1b) in critically ill patients did not reduce pneumonia or mortality and was stopped early for safety, contradicting simplistic influencer narratives that enhancing immune activity is uniformly beneficial in states of presumed immune dysregulation.[21][15] Editorials on innate immune regulation highlight that mechanisms of immune dysregulation are complex, multifactorial, and still not fully understood, cautioning against oversimplified claims that minor lifestyle changes can reliably “reset” or “rebalance” immune regulation in serious disease.[6] Overall, the rigorous literature supports immune dysregulation as a specific mechanistic concept tied to defined diseases, but not as an imprecise, universal explanation or easy therapeutic target in the way influencers often present it.
- Mainstream view
- Mainstream immunology and clinical medicine recognize immune dysregulation as a central mechanism in many conditions including autoimmune diseases, primary immune regulatory disorders, inborn errors of immunity, chronic inflammatory diseases (such as IBD), some cancers, and states like critical-illness-related immunosuppression.[2][3][5][7][9][14][20][21][22] It is viewed as a spectrum of abnormal immune control—ranging from insufficient responses (immunodeficiency) to excessive or misdirected responses (autoimmunity, hyper
“gut health, hormonal dysfunction, environmental toxins, immune dysregulation or food sensitivities”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Manipulation
False Authority
transcript · cited
A chiropractor (DC) is licensed for musculoskeletal/spine care, not for diagnosing or managing systemic internal diseases like diabetes or heart disease. Using 'Dr.' and 'holistic doctor' to imply general medical competence is a classic false authority grift. Likely motive: To attract patients with serious chronic conditions who would otherwise see an MD/DO, bypassing standard insurance and medical oversight.
“I'm Dr. Chloe Skidmore, a functional holistic doctor who specializes in chronic disease, internal disorders, and women's health”
Fear Mongering
transcript · cited
Frames standard medical care as negligent ('treats symptoms but rarely addresses root cause') to create fear that the patient's condition is being missed, pushing them toward unproven 'root cause' testing. Likely motive: To justify expensive, non-standard lab panels and supplement protocols that insurance won't cover.
“Traditional medicine treats symptoms but rarely addresses the root cause. In my practice, we uncover the underlying root issues.”
Commerce & grift map
Chloe Skidmore uses a DC license to claim authority over systemic diseases (diabetes, heart disease), creating fear that 'traditional medicine' misses root causes. This drives patients to expensive, non-standard specialty labs and unproven nutraceuticals. The lack of disclosure hides the financial incentive, and the cash-only model avoids insurance scrutiny.
No FTC-style compensation disclosure
compensationDisclosures · scan
Promotion of nutraceuticals and herbals without disclosure
supplement_brand
Host self-funnel around guest content
guestCollaboration · selfFunnel
Host routes viewers to their own consult/booking links around the guest segment.
Supplements pitched
- Nutraceuticals and Herbals
“I utilize nutraceuticals, herbals, acupuncture, emotional support techniques and fascial therapies in my practice”
Labs pitched
- Specialty Lab Testing
“Specialty tests provide a deeper understanding into gut health, hormonal dysfunction, environmental toxins, immune dysregulation or food sensitivities”
How the money flows
- Supplement brand dealUndisclosed Promotion of nutraceuticals and herbals without disclosure “I utilize nutraceuticals, herbals...”
“I utilize nutraceuticals, herbals...”
- Lab testing referralUndisclosed Promotion of specialty lab panels without disclosure “I utilize a variety of laboratory tests for identifying root issues”
“I utilize a variety of laboratory tests for identifying root issues”
Sponsors and advertisers
Brands, advertisers, and agencies connected to this content, based on what it promotes and discloses.
- Nutraceuticals and Herbals (Generic)Brand
Promoted commerce partner
- Specialty Lab Testing (Generic)Brand
Promoted commerce partner
- Nutraceuticals and HerbalsBrand
Named on a surface without a compensation disclosure
- Specialty Lab TestingBrand
Named on a surface without a compensation disclosure
Credentials & scope
Glossary: Chiropractor (“Dr.”)
Stated: DR, Chiropractor
Verified against the federal provider registry: DC · Chiropractor · KS license 01-06113.
Chloe Skidmore holds a Chiropractor (chiropractor) license but advertises as a 'functional holistic doctor' specializing in systemic internal diseases (diabetes, heart disease), which is outside the scope of chiropractic board rules. This is credential inflation: using a narrow musculoskeletal license to imply broad medical authority.
- DC, Doctor of Chiropractic
A state-regulated professional license for spinal adjustment and musculoskeletal/nervous system care. Does not include general internal medicine, prescription pharmacology, or primary disease management.
State Chiropractic Board: Limited to evaluation/treatment of musculoskeletal and nervous-system conditions via spinal adjustment. Cannot diagnose/treat systemic diseases like diabetes or heart disease.
Permitted scope vs advertised
Kansas State Board of Healing Arts (Chiropractic) · Confidence: medium
Kansas chiropractic law allows chiropractors to examine, analyze and diagnose the human body and its diseases using physical methods, and to treat the human body by manual, mechanical, electrical or natural methods, physiotherapy, and foods or food concentrates, but expressly prohibits prescribing or administering medicines or drugs in materia medica.[1][3] The statute language is broad on diagnosis and on use of foods and natural methods, but does not affirmatively authorize chiropractors to practice primary medical management of systemic internal diseases like diabetes or heart disease.[3] Their core scope centers on chiropractic adjustments and physical/natural methods, not pharmacologic or full-scope primary care.[1][3]
What this license permits
- Spinal adjustment and manipulation
- Musculoskeletal evaluation and treatment
- Soft-tissue and rehabilitative care
- Headache care within musculoskeletal scope
20 of 20 advertised activities fall outside permitted scope.
| Advertised | Verdict |
|---|---|
| Diagnosing and managing diabetes, heart disease, hormonal imbalances, and digestive problems Rule: K.S.A. chiropractic practice definition as summarized in Kansas scope overview Kansas law allows chiropractors to examine, analyze and diagnose the human body and its diseases using physical methods, but does not affirmatively authorize comprehensive medical management of systemic internal diseases like diabetes, heart disease, and hormonal disorders as primary-care conditions.[3] | Outside scope |
| Listed service Thyroid conditions Rule: K.S.A. chiropractic practice definition (diagnosis by physical methods)[3] Although Kansas chiropractors may diagnose the human body and its diseases using physical methods, the statute does not affirmatively authorize diagnosis and medical management of endocrine diseases such as thyroid disorders as a distinct part of chiropractic practice. | Outside scope |
| Listed service Autoimmunity Rule: K.S.A. chiropractic practice definition (treat the human body by manual, mechanical, electrical or natural methods)[3] Autoimmune diseases are systemic internal medical conditions, and Kansas chiropractic statutes do not affirmatively expand scope to diagnosing and managing systemic autoimmune disorders beyond chiropractic and physical/natural methods. | Outside scope |
| Listed service Hashimoto’s Rule: K.S.A. chiropractic practice definition (diagnose the human living body and its diseases by physical methods)[3] Hashimoto’s thyroiditis is a specific autoimmune endocrine disease, and Kansas law does not affirmatively authorize chiropractors to act as diagnosing and managing clinicians for named systemic autoimmune endocrine disorders. | Outside scope |
| Listed service IBS & SIBO Rule: K.S.A. chiropractic practice definition (foods, food concentrates, or food extracts; physical methods)[3] Irritable bowel syndrome and small intestinal bacterial overgrowth are internal gastrointestinal diagnoses, and Kansas statutes do not affirmatively grant chiropractors authority to diagnose and medically manage such systemic digestive diseases beyond general nutritional or wellness counseling. | Outside scope |
| Listed service Anxiety & Depression Rule: K.S.A. chiropractic practice definition (diagnose by physical, thermal, or manual method)[3] Mental health diagnosis and management of anxiety and depression are not affirmatively authorized in Kansas chiropractic practice statutes, which focus on physical examination and natural/physical treatments rather than psychiatric diagnosis or therapy. | Outside scope |
| Listed service Type II Diabetes Rule: K.S.A. chiropractic practice definition (treat by foods, food concentrates, or food extracts; prohibition on prescribing medicines or drugs)[1][3] Type II diabetes is a systemic metabolic disease typically requiring medical management, and Kansas chiropractic law does not affirmatively permit chiropractors to function as primary diagnosticians and managers of diabetes beyond general nutritional advice. | Outside scope |
| Listed service PCOS & Endometriosis Rule: K.S.A. chiropractic practice definition (examine and diagnose by physical methods; treat via natural methods)[3] Polycystic ovary syndrome and endometriosis are gynecologic/endocrine medical conditions, and the Kansas chiropractic statute does not affirmatively authorize diagnosis and direct management of such internal reproductive diseases. | Outside scope |
| Listed service Chronic Fatigue Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
| Diagnosing and managing systemic internal diseases (diabetes, heart disease) outside musculoskeletal scope Rule: K.S.A. chiropractic practice definition; prohibition on prescribing medicines or drugs[1][3] Though Kansas chiropractors may diagnose the human body and its diseases and use foods or natural methods, the law does not affirmatively authorize comprehensive diagnosis and medical management of systemic internal diseases such as diabetes and heart disease outside chiropractic and musculoskeletal-related care. | Outside scope |
| Diagnosing and managing diabetes and heart disease Rule: K.S.A. chiropractic practice definition (foods and natural methods; restriction on drugs)[1][3] Primary diagnosis and longitudinal management of diabetes and heart disease constitute medical care, and Kansas chiropractic statutes do not affirmatively grant chiropractors authority to act as primary medical managers of these systemic diseases. | Outside scope |
| Prescribing natural supplements to treat root causes of chronic disease Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Listed service Fertility and pregnancy support Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Listed service Immune dysregulation Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Listed service More About Conditions Seen Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Prescribing supplements to treat root causes of disease Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Diagnosing immune dysregulation and food sensitivities via specialty labs Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Managing fertility and pregnancy support as medical treatment Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Specialty lab testing for immune dysregulation and food sensitivities Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Prescribing nutraceuticals for root cause treatment Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
Sources: Kansas State Board of Healing Arts – Chiropractic (via Kansas scope summary) (official), Kansas State Board of Healing Arts – Homepage (official), Federation of Chiropractic Licensing Boards – Kansas State Board of Healing Arts, 233 CMR, § 4.01 - Scope of Practice | State Regulations | US Law
Disclaimer hypocrisy
Chloe Skidmore hides behind a footer disclaimer claiming 'not medical advice' while simultaneously prescribing supplements and diagnosing systemic diseases like diabetes and heart disease—a classic disclaimer hypocrisy that shields liability while practicing medicine.
When the service is also outside their license
This pattern gets sharper when the service routed to your FSA or HSA also sits outside the practitioner's licensed scope. A provider advertising to diagnose or treat conditions their state board does not authorize is already operating past the edge of their license. Pair that with a cash-pay, FSA or HSA funded model that keeps the work away from any insurer or government program, and there is no claims reviewer, no audit trail, and no payer left to ask whether the care was appropriate or even within the provider's remit. The tax advantaged dollars do the paying, the patient carries the substantiation, and the scope question never reaches anyone with the authority to raise it.
Validated associated properties
Surfaces tied to this Doc Bro by domain, branding, or funnel routing. Third-party platforms are labeled as routes, not as owned properties.
Analyzed
- OwnedOfficial site (truehealthks.com)
Tip the jar
Report useful? Optional tips help keep scans, archives, and literature cross-checks running. They never change conclusions.
Submission ddxK1l9Y60aX2F8M_wPEB
Fight disinformation
Log a public thread where Chloe Skidmore is spreading nonsense, get a copy-paste reply with this report link.
Reply snippets
Before you buy the protocol: Dr. Trust Me Bro fact-checked Chloe Skidmore's claims with peer-reviewed sources, https://drtrustmebro.com/analyze/ddxK1l9Y60aX2F8M_wPEB. White-coat charisma isn't evidence.
Full DTMB scan on Chloe Skidmore: https://drtrustmebro.com/analyze/ddxK1l9Y60aX2F8M_wPEB
Drop these in YouTube comments, Reddit threads, and forums, link back to this scan, not vibes.
Recent mentions (this doc)
No conversation links logged yet. Be the first above.
Nudge the Doc Bro
We could not find a public contact email for Chloe Skidmore. Reach them through their own site and ask them to review this dossier and correct anything we got wrong.
Know someone who can help?
If you think someone has firsthand information about Chloe Skidmore, send them an encouraging note. We email a short, respectful message with this report and clear instructions on how to write in, on the record or anonymously.
Whambulance
Challenge this scan or Wall of Fame entry for Chloe Skidmore. Public log, not legal arbitration.
Public challenge log
No posted Wall of Fame challenges linked yet.
Challenges are public on the Wall of Fame card. DTMB does not remove entries for hurt feelings, primary sources or copy corrections only.
File a challenge
Include in your email:
- Doc Bro ID: joaXp6GXCYwviKgDfhfuu
- Wall entry: /influencer/joaXp6GXCYwviKgDfhfuu
- Analysis ID: ddxK1l9Y60aX2F8M_wPEB
- Source: https://truehealthks.com
- Why this entry or scan should change
- Supporting links (one per line)
- Your business email (for verified disputes)
Verified challenges are posted publicly on the report. Public log, not legal arbitration.
Citations
Peer-reviewed and index sources cited in this report.
- [1] Recommendations for Early and Comprehensive Management of Type 2 Diabetes and Its Related Cardio-Renal Complications
- [2] New Perspectives in Management of Cardiovascular Risk Among People With Diabetes
- [3] 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2024.
- [4] 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2023.
- [5] Selenium Supplementation in Patients with Hashimoto Thyroiditis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
- [6] Guideline-Driven Management of Hypertension: An Evidence-Based Update.
- [7] Risk factors for postpartum depression: An evidence-based systematic review of systematic reviews and meta-analyses.
- [8] ASPEN-FELANPE Clinical Guidelines.
- [9] Selenium Supplementation in Patients with Hashimoto Thyroiditis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
- [10] Clinical efficacy of selenium supplementation in patients with Hashimoto thyroiditis: A systematic review and meta-analysis
- [11] Selenium Supplementation for Hashimoto's Thyroiditis: Summary of a Cochrane Systematic Review
- [12] Selenium supplementation and placebo are equally effective in improving quality of life in patients with hypothyroidism
- [13] PubMed indexed study
- [14] PubMed indexed study
- [15] PubMed indexed study
- [16] Food groups and risk of chronic disease: a protocol for a systematic review and network meta-analysis of cohort studies
- [17] Standardised Outcome Reporting for the Nutrition Management of Complex Chronic Disease: A Rapid Review
- [18] Nutrition and Chronic Conditions
- [19] Evaluation of the Quality of Evidence of the Association of Foods and Nutrients With Cardiovascular Disease and Diabetes
- [20] Antioxidants and Fertility in Women with Ovarian Aging: A Systematic Review and Meta-Analysis.
- [21] Effects of Levothyroxine Treatment on Fertility and Pregnancy Outcomes in Subclinical Hypothyroidism: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- [22] Fibroids and natural fertility: a systematic review and meta-analysis.
- [23] Therapeutic management in women with a diminished ovarian reserve: a systematic review and meta-analysis of randomized controlled trials.
- [24] Antioxidants and Fertility in Women with Ovarian Aging: A Systematic Review and Meta-Analysis
- [25] Antioxidants for female subfertility.
- [26] The Role of Antioxidant Enzymes in the Ovaries
- [27] Oxidative stress and antioxidants: exposure and impact on female fertility.
- [28] PubMed indexed study
- [29] PubMed indexed study
- [30] PubMed indexed study
- [31] When Is Parenteral Nutrition Appropriate?
- [32] Editorial: Immune dysregulation in inborn errors of immunity
- [33] Rebooting Regulatory T Cell and Dendritic Cell Function in Immune-Mediated Inflammatory Diseases: Biomarker and Therapy Discovery under a Multi-Omics Lens
- [34] Guardians of Immunity: Advances in Primary Immunodeficiency Disorders and Management
- [35] Editorial: Negative Regulators of Innate Immunity and Their Role in Host Responses to Injury and Infection